Production (Stage)
Sharp Therapeutics Corp.
SHRX.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.25M | -112.70K | -112.70K | -- | -1.23M |
| Total Depreciation and Amortization | 26.90K | 24.90K | 24.90K | -- | 42.20K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.99M | -898.00K | -898.00K | -- | 623.80K |
| Change in Net Operating Assets | -152.60K | -197.30K | -197.30K | -- | -36.00K |
| Cash from Operations | -1.39M | -1.18M | -1.18M | -- | -600.00K |
| Capital Expenditure | -- | 0.00 | 0.00 | -- | -31.10K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 2.60K | 2.60K | -- | -- |
| Cash from Investing | -- | 2.60K | 2.60K | -- | -31.10K |
| Total Debt Issued | -- | 475.00K | 475.00K | -- | -- |
| Total Debt Repaid | -50.00K | -168.40K | -168.40K | -- | -50.00K |
| Issuance of Common Stock | -- | 2.48M | 2.48M | -- | 500.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 14.80K | 14.80K | -- | -- |
| Cash from Financing | -50.00K | 2.80M | 2.80M | -- | 450.00K |
| Foreign Exchange rate Adjustments | -26.00K | 3.00K | 3.00K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.47M | 1.63M | 1.63M | -- | -181.10K |